Spectroscopic studies and molecular modeling for understanding the interactions between cholesterol and cyclodextrins

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 13, Issue 3, 2010, Pages 362-377

  Castagne, Delphine ^a   Dive, Georges ^a   Evrard, Brigitte ^a   Frédérich, Michel ^a   Piel, Géraldine ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE; CHOLESTEROL; DIMETHYL BETA CYCLODEXTRIN; METHYLATED BETA CYCLODEXTRIN; TRIMETHYL BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOTOXICITY; MOLECULAR MODEL; NUCLEAR OVERHAUSER EFFECT; PROTEIN LIPID INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; SOLUBILIZATION; SPECTROSCOPY; STOICHIOMETRY;

EID: 78650373708     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3bs34     Document Type: Article

References (41)

1. Kilsdonk E.P., Yancey P.G., Stoudt G.W., Bangerter F.W., Johnson W.J., Phillips M.C., Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem., 1995; 270:17250-17256.
2. Yancey P.G., Rodrigueza W.V., Kilsdonk E.P., Stoudt G.W., Johnson W.J., Phillips M.C., Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem., 1996; 271:16026-16034.
3. Leroy-Lechat F., Wouessidjewe D., Andreux J.-P., Puisieux F., Duchêne D. Evaluation of the cytotoxicity of cyclodextrins and hydroxypropylated derivatives. Int. J. Pharm., 1994; 101:97-103.
4. Castagne D., Fillet M., Delattre L., Evrard B., Nusgens B., Piel G. Study of the cholesterol extraction capacity of β-cyclodextrin and its derivatives, relationships with their effects on endothelial cell viability and on membrane models. J. Incl. Phenom. Macrocycl. Chem., 2009; 63:225-231.
5. Loftsson T., Vogensen S.B., Brewster M.E., Konradsdottir F. Effects of cyclodextrins on drug delivery through biological membranes. J. Pharm. Sci., 2007; 96:2532-2546.
6. Marttin E., Verhoef J.C., Merkus F.W.H.M. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs. J. Drug Target., 1998; 6:17-36.
7. Belhadj Salem L., Bosquillon C., Dailey L.A., Delattre L., Martin G.P., Evrard B., Forbes B. Sparing methylation of β-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro. J. Control. Release, 2009; 136:110-116.
8. Christian A.E., Haynes M.P., Phillips M.C., Rothblat G.H. Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res., 1997; 38:2264-2272.
9. Castagne D., Evrard B., Nusgens B., Piel G. Effect of β-cyclodextrin and its derivatives on caveolae disruption, relationships with their cholesterol extraction capacities. J. Incl. Phenom. Macrocycl. Chem., 2009; doi:10.1007/s10847-009-9718-3 (Online first).
10. Brown D.A., London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol., 1998; 14:111-136.
11. Quest A.F., Leyton L., Parraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem. Cell Biol., 2004; 82:129-144.
12. Ilangumaran S., Hoessli D.C. Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem. J., 1998; 335:433-440.
13. Barenholz Y. Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications. Subcell. Biochem., 2004; 37:167-215.
14. Lambert D., O'Neill C.A., Padfield P.J. Depletion of Caco-2 cell cholesterol disrupts barrier function by altering the detergent solubility and distribution of specific tight-junction proteins. Biochem. J., 2005; 387:553-560.
15. Lambert D., O'Neill C.A., Padfield P.J. Methyl-β-cyclodextrin increases permeability of caco-2 cell monolayers by displacing specific claudins from cholesterol rich domains associated with tight junctions. Cell. Physiol. Biochem., 2007; 20:495-506.
16. Lynch R.D., Francis S.A., McCarthy K.M., Casas E., Thiele C., Schneeberger E.E. Cholesterol depletion alters detergent-specific solubility profiles of selected tight junction proteins and the phosphorylation of occludin. Exp. Cell Res., 2007; 313:2597-2610.
17. Sugibayashi K., Onuki Y., Takayama K. Displacement of tight junction proteins from detergent-resistant membrane domains by treatment with sodium caprate. Eur. J. Pharm. Sci., 2009; 36:246-253.
18. Ohvo-Rekila H., Akerlund B., Slotte J.P. Cyclodextrin-catalyzed extraction of fluorescent sterols from monolayer membranes and small unilamellar vesicles. Chem. Phys. Lipids, 2000; 105:167-178.
19. Piel G., Piette M., Barillaro V., Castagne D., Evrard B., Delattre L. Study of the interaction between cyclodextrins and liposome membranes: effect on the permeability of liposomes. J. Incl. Phenom. Macrocycl. Chem., 2007; 57:309-311.
20. Beseničar M.P., Bavdek A., Kladnik A., Macek P., Anderluh G. Kinetics of cholesterol extraction from lipid membranes by methyl-β-cyclodextrin - A surface plasmon resonance approach. Biochim. Biophys. Acta-Biomembr., 2008; 1778:175-184.
21. Piel G., Piette M., Barillaro V., Castagne D., Evrard B., Delattre L. Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes. Int. J. Pharm., 2007; 338:35-42.
22. Piel G., Moutard S., Perly B., Henry de Hassonville S.H., Bertholet P., Barillaro V., Piette M., Delattre L., Evrard B. Comparison of two methods currently used to determine the interaction between cyclodextrins and drugs: phase solubility diagrams and NMR spectroscopy. J. Drug Deliv. Sci. Technol., 2004; 14:87-91.
23. Ravichandran R., Divakar S. Inclusion of ring a of cholesterol inside the β-cyclodextrin cavity: Evidence from oxidation reactions and structural studies. J. Inclusion Phenom. Mol. Recogn., 1998; 30:253-270.
24. Nishijo J., Moriyama S., Shiota S. Interactions of cholesterol with cyclodextrins in aqueous solution. Chem. Pharm. Bull., 2003; 51:1253-1257.
25. Nishijo J., Moriyama S., Shiota S., Kamigauchi M., Sugiura M. Interaction of heptakis (2,3,6-tri-O-methyl)-β-cyclodextrin with cholesterol in aqueous solution. Chem. Pharm. Bull., 2004; 52:1405-1410.
26. Piel G., Dive G., Evrard B., Van Hees T., Henry de Hassonville S., Delattre L. Molecular modeling study of β- and γ-cyclodextrin complexes with miconazole. Eur. J. Pharm. Sci., 2001; 13:271-279.
27. Henry de Hassonville S., Perly B., Piel G., Van Hees T., Barillaro V., Bertholet P., Delattre L., Evrard B. Inclusion complexes of cyproterone acetate with cyclodextrins in aqueous solution. J. Incl. Phenom. Macrocycl. Chem., 2002; 44:289-292.
28. 1H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions. J. Pharm. Pharm. Sci., 2005; 8:147-158.
29. Ziémons E., Dive G., Debrus B., Barillaro V., Frédérich M., Lejeune R., Angenot L., Delattre L., Thunus L., Hubert P. Study of the physicochemical properties in aqueous medium and molecular modeling of tagitinin C/cyclodextrin complexes. J. Pharm. Biomed. Anal., 2007; 43:910-919.
30. Barillaro V., Dive G., Bertholet P., Evrard B., Delattre L., Ziémons E., Piel G. Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: Molecular modeling studies. Int. J. Pharm., 2007; 342:152-160.
31. Dewar M.J.S., Zoebisch E.G., Healy E.F., Stewart J.J.P. AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc., 1985; 107:3902-3909.
32. Dive G., Dehareng D., Ghuysen J.M. Energy analysis on small to medium sized H-bonded complexes. Theor. Chim. Acta, 1993; 85:409-421.
33. Jensen F. Introduction to computational chemistry. John Wiley & Sons, Wiley-VCH, Chichester, UK, 1999.
34. Hariharan P.C., Pople J.A. The influence of polarization functions on molecular orbital hydrogenation energies. Theor. Chim. Acta, 1973, 28:213-222.
35. Becke A.D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys., 1993; 98:5648-5652.
36. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Montgomery J.A. Jr., Vreven T., Kudin K.N., Burant J.C., Millam J.M., Iyengar S.S., Tomasi J., Barone V., Mennucci B., Cossi M., Scalmani G., Rega N., Petersson G.A., Nakatsuji H., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Klene M., Li X., Knox J.E., Hratchian H.P., Cross J.B., Adamo C., Jaramillo J., Gomperts R., Stratmann R.E., Yazyev O., Austin A.J., Cammi R., Pomelli C., Ochterski J.W., Ayala P.Y., Morokuma K., Voth G.A., Salvador P., Dannenberg J.J., Zakrzewski V.G., Dapprich S., Daniels A.D., Strain M.C., Farkas O., Malick D.K., Rabuck A.D., Raghavachari K., Foresman J.B., Ortiz J.V., Cui Q., Baboul A.G., Clifford S., Cioslowski J., Stefanov B.B., Liu G., Liashenko A., Piskorz P., Komaromi I., Martin R.L., Fox D.J., Keith T., Al-Laham M.A., Peng C.Y., Nanayakkara A., Challacombe M., Gill P.M.W., Johnson B, Chen W, Wong M.W., Gonzalez C., Pople J.A., Gaussian, Inc., Wallingford CT, 2004. Gaussian 03, Revision D.02.
37. Armspach D. Gattuso G., Koniger R., Stoddart J. Cyclodextrins in Bioorganic Chemistry: carbohydrates Ch 12, Ed. Hecht Sidney M. Oxford University Press 1999
38. Hazekamp A., Verpoorte R. Structure elucidation of the tetrahydrocannabinol complex with randomly methylated β-cyclodextrin. Eur. J. Pharm. Sci., 2006; 29: 340-347.
39. Bakkour Y. Etude par RMN des complexes d'inclusion avec des cyclodextrines natives et polymérisées. Université des Sciences et Technologies de Lille 1, Lille, France, 2005.
40. Comini S., Mentink L. Refining mixtures containing complexes of cyclodextrins with lipophilic compounds such as fatty acids. Eur Pat. Appl. EP 440539, 1991.
41. Szente L., Szejtli J. Cyclodextrins as food ingredients. Trends Food Sci. Technol., 2004; 15:137-142.